Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Hepatitis C virus infection in children and adolescents
G Indolfi, P Easterbrook, G Dusheiko… - The lancet …, 2019 - thelancet.com
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and associated
morbidity and mortality worldwide. Short-course, oral, curative, direct-acting antiviral …
morbidity and mortality worldwide. Short-course, oral, curative, direct-acting antiviral …
[PDF][PDF] Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta‐analysis
There is an increased awareness of hepatitis B (HBV) reactivation in chronic hepatitis C
(CHC) patients coinfected with HBV treated with pan‐oral direct‐acting antiviral agents …
(CHC) patients coinfected with HBV treated with pan‐oral direct‐acting antiviral agents …
Risk factors and prevention of viral hepatitis-related hepatocellular carcinoma
X Zhang, L Guan, H Tian, Z Zeng, J Chen… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is a common cancer in the world, and its incidence is
increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are …
increasing yearly. Hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection are …
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents
WF Hsu, HC Lai, WP Su, CH Lin, PH Chuang… - BMC …, 2019 - Springer
Background Studies on temporal changes in noninvasive fibrosis indices and liver stiffness
measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting …
measurement (LSM) in patients with chronic hepatitis C (CHC) treated with direct-acting …
Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: a real‐world nationwide hepatitis C virus registry programme in Taiwan
CY Chen, CF Huang, PN Cheng, KC Tseng… - Liver …, 2021 - Wiley Online Library
Background/aims Direct‐acting antivirals (DAAs) are highly effective in treating chronic
hepatitis C virus (HCV)‐infected patients. The real‐world treatment outcome in Taiwanese …
hepatitis C virus (HCV)‐infected patients. The real‐world treatment outcome in Taiwanese …
[HTML][HTML] Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection
Background & Aims The outcome of HBV infection, including the dynamics of HBsAg and
HBV virological reactivation, among patients coinfected with HCV receiving direct-acting …
HBV virological reactivation, among patients coinfected with HCV receiving direct-acting …